MINERVA NEUROSCIENCES INC's ticker is NERV and the CUSIP is 603380106. A total of 71 filers reported holding MINERVA NEUROSCIENCES INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $200,000 | -42.7% | 33,247 | -32.2% | 0.00% | -100.0% |
| Q4 2019 | $349,000 | -10.3% | 49,047 | -2.4% | 0.00% | 0.0% |
| Q3 2019 | $389,000 | +17.5% | 50,247 | -14.6% | 0.00% | – |
| Q2 2019 | $331,000 | -26.4% | 58,847 | +2.8% | 0.00% | -100.0% |
| Q1 2019 | $450,000 | +29.3% | 57,247 | +11.0% | 0.00% | 0.0% |
| Q4 2018 | $348,000 | -44.7% | 51,593 | +3.0% | 0.00% | 0.0% |
| Q3 2018 | $629,000 | +53.0% | 50,093 | +0.6% | 0.00% | 0.0% |
| Q2 2018 | $411,000 | +32.2% | 49,793 | 0.0% | 0.00% | – |
| Q1 2018 | $311,000 | +3.3% | 49,793 | 0.0% | 0.00% | – |
| Q4 2017 | $301,000 | -21.0% | 49,793 | -0.6% | 0.00% | -100.0% |
| Q3 2017 | $381,000 | -29.1% | 50,093 | -17.5% | 0.00% | 0.0% |
| Q2 2017 | $537,000 | +144.1% | 60,693 | +124.0% | 0.00% | – |
| Q1 2017 | $220,000 | -29.9% | 27,100 | +1.3% | 0.00% | -100.0% |
| Q4 2016 | $314,000 | -19.9% | 26,743 | -3.7% | 0.00% | 0.0% |
| Q3 2016 | $392,000 | – | 27,776 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Index Venture Associates V Ltd | 898,954 | $11,282,000 | 1.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 842,391 | $10,572,000 | 1.21% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,319,220 | $16,556,000 | 0.91% |
| NORTHPOINTE CAPITAL LLC | 282,639 | $3,547,000 | 0.51% |
| Cormorant Asset Management, LP | 607,903 | $7,629,000 | 0.50% |
| New Leaf Venture Partners, L.L.C. | 130,000 | $1,632,000 | 0.30% |
| FEDERATED HERMES, INC. | 7,535,287 | $94,568,000 | 0.22% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 61,329 | $770,000 | 0.16% |
| DAFNA Capital Management LLC | 26,907 | $338,000 | 0.14% |
| Kazazian Asset Management, LLC | 10,026 | $126,000 | 0.12% |